SUMO and ubiquitin modifications in Nipah virus matrix trafficking and function
SUMO and ubiquitin modifications in Nipah virus matrix trafficking and function
批准号:
8456594
负责人:
Mickey Joseph Pentecost
金额:
$5.39万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-02-01 至 2015-01-31
关键词:
AffectAnimalsAntiviral AgentsAsiansBindingBiologicalBiological AssayBiological ProcessCell NucleolusCell NucleusCell membraneCell surfaceCellsCellular biologyChiropteraCollaborationsComplementComplexCytoplasmDiseaseEncephalitisEnvironmentFamilyFluorescenceFrequenciesFruitGap JunctionsGoalsHenipavirusHumanImmuneInfectionInterferon Type IInvestigationLeadLicensingLifeLigaseLightLinkLysineMediatingMedicineMembraneModificationNipah VirusNuclearNuclear StructureOccupationsParamyxoviridaeParamyxovirusPathogenicityPathway interactionsPatientsPost-Translational Protein ProcessingPropertyProteinsRNA VirusesReagentRecombinantsRegulationResearchRoleSiteStructural ProteinSystemTechniquesTherapeuticTherapeutic InterventionUbiquitinVaccinesViralViral PathogenesisVirionVirulenceVirusWorkcellular imagingin vivoinnovationinterestmortalitymulticatalytic endopeptidase complexmultiple myeloma M Proteinnew therapeutic targetnovelpathogenpositional cloningpublic health relevancerespiratorytooltrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Nipah (NiV) and Hendra (HeV) viruses are the deadliest human pathogens within the Paramyxoviridae family, which include human and animal pathogens of global biomedical importance. NiV and HeV are zoonotic viruses that can be transmitted directly to humans or intermediate amplifying hosts from their natural reservoirs in fruit bats. NiV and HeV infections cause respiratory and encephalitic illnesses, and NiV's mortality rate in humans can exceed 70 percent. Thus, NiV and HeV are the only paramyxoviruses classified BSL4 pathogens due to their extreme pathogenicity and lack of licensed vaccines or effective therapeutics. Paramyxoviruses are negative-sense RNA viruses that replicate in the cytoplasm. Their matrix structural protein organizes virion assembly at the plasma membrane and mediates viral budding from the cell surface. Curiously, the matrix protein of several paramyxoviruses has been observed to traffic in and out of the nucleus, although the functional relevance of paramyxovirus M proteins entering the nucleus has been unclear. We also found that NiV-M shuttles between the cytoplasmic and the nuclear compartments. However, our investigations established that proper nuclear-cytoplasmic trafficking of NiV-M, regulated by the ubiquitin-proteasome system, is critical for its functional localization to the plasma membrane, and its subsequent ability to mediate viral budding. Further study revealed a trove of NiV-M-interacting partners that places NiV-M at the nexus of multiple cell biological processes that are of contemporary scientific interest, including the cros regulation between the SUMO and ubiquitin-proteasome system in modulating subnuclear trafficking, and the function of PML bodies, nuclear structures involved in cellular antiviral defense. The goal of this application is to determine the role of SUMO and ubiquitin modifications in Nipah virus matrix trafficking and function. Understanding the basic cell biology of NiV-M will not only shed light on the properties that contribute to the unusually high virulence
of this virus, but might also reveal host-pathogen interactions that have broader implications for viral pathogenesis in general. To understand the biological implications of NiV-M's complex intracellular sojourn, we propose the following three specific aims: (1) Identify and characterize post-translational modifications of NiV-M, focusing on the SUMO- and ubiquitin-proteasome pathway, and (2) define the functional roles for matrix post-translational modification in relation
to viral pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SUMO and ubiquitin modifications in Nipah virus matrix trafficking and function
-
批准号:8609476
-
项目类别:
-
资助金额:$5.7万
-
财政年份:2013
-
负责人:Mickey Joseph Pentecost
-
依托单位:
海外基金